Guía de Práctica Clínica sobre Diabetes tipo 2 - Euskadi.net
Guía de Práctica Clínica sobre Diabetes tipo 2 - Euskadi.net
Guía de Práctica Clínica sobre Diabetes tipo 2 - Euskadi.net
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
139. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C,<br />
et al. Efficacy and safety of cholesterol-lowering treatment: prospective<br />
meta-analysis of data from 90,056 participants in 14 randomised<br />
trials of statins. Lancet. 2005;366(9493):1267-78.<br />
140. Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol.<br />
2006;97(8A):52C-60C.<br />
141. Pfeffer MA, Keech A, Sacks FM, Cobbe SM, Tonkin A, Byington RP,<br />
et al. Safety and tolerability of pravastatin in long-term clinical trials:<br />
prospective Pravastatin Pooling (PPP) Project. Circulation.<br />
2002;105(20):2341-6.<br />
142. Effects of long-term fenofibrate therapy on cardiovascular events in<br />
9795 people with type 2 diabetes mellitus (the FIELD study): randomised<br />
controlled trial. The Lancet. 2005;366(9500):1849-61.<br />
143. Tight blood pressure control and risk of macrovascular and microvascular<br />
complications in type 2 diabetes: UKPDS 38. UK Prospective<br />
<strong>Diabetes</strong> Study Group. BMJ. 1998;317(7160):703-13.<br />
144. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius<br />
S, et al. Effects of intensive blood-pressure lowering and low-dose<br />
aspirin in patients with hypertension: principal results of the Hypertension<br />
Optimal Treatment (HOT) randomised trial. HOT Study<br />
Group. Lancet. 1998;351(9118):1755-62.<br />
145. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood<br />
pressure control in normotensive type 2 diabetic patients on albuminuria,<br />
retinopathy and strokes. Kidney Int. 2002;61(3):1086-97.<br />
146. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, et al.<br />
Effects of different blood pressure-lowering regimens on major cardiovascular<br />
events in individuals with and without diabetes mellitus:<br />
results of prospectively <strong>de</strong>signed overviews of randomized trials. Arch<br />
Intern Med. 2005;165(12):1410-9.<br />
147. Vijan S. Hypertension in diabetes. In: BMJ Publishing Group, editor.<br />
Clinical Evi<strong>de</strong>nce. 2006. p. 1-12.<br />
148. Mancia G, Brown M, Castaigne A, <strong>de</strong> LP, Palmer CR, Rosenthal T,<br />
et al. Outcomes with nifedipine GITS or Co-amilozi<strong>de</strong> in hypertensive<br />
diabetics and nondiabetics in Intervention as a Goal in Hypertension<br />
(INSIGHT).[see comment]. Hypertension. 2003;41(3):431-6.<br />
149. Grossman E, Messerli FH. Are calcium antagonists beneficial in diabetic<br />
patients with hypertension? Am J Med. 2004;116(1):44-9.<br />
142 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS
Change language